newsfilter
← Latest News
GlobeNewswire·

Aileron Therapeutics Announces a 1-for-20 Reverse Stock Split

BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients' lives, today